Vancomycin Powder for Concentrate for Solution for Infusion 500mg – PL 30306/0444 Vancomycin Powder for Concentrate for Solution for Infusion 1000mg – PL 30306/0445 Actavis is recalling all remaining stock…
Read More
News Archive • Page 6 of 8 • Fortissa
The Medicines and Healthcare Products Regulatory Agency (MHRA) today announced that it has seized £8.6 million of counterfeit and unlicensed medicines in the UK, including huge hauls of potentially harmful…
Organized crime networks targeted in INTERPOL-coordinated Operation Pangea VII LYON, France – Nearly 200 enforcement agencies across 111 countries have taken part in Operation Pangea VII targeting criminal networks behind…
Class 2 Medicines Recall (action within 48 hours): Fybogel Orange – Reckitt Benckiser Healthcare (UK) Limited Reckitt Benckiser Healthcare (UK) Limited Fybogel Orange (Ispaghula Husk) PL 00063/0026 Reckitt Benckiser Healthcare…
Gilead Sciences Limited is recalling the below stated batches of Viread 245 mg Film-Coated Tablets due to the possible presence of silicone rubber. A failure of equipment used in the…
Class 2 Medicines Recall (Action within 48 hours): COSOPT Preservative-Free, 20mg/ml +5mg/ml, eye drops, solution, single-dose container – Merck Sharp & Dohme Limited (EL (14)A/02) (Dorzolamide / Timolol) PL 00025/0698…
Teva UK Ltd has informed MHRA that an incorrect dosing instruction is present in the Patient Information Leaflet for Irbesartan / Hydrochorothiazide, Teva strength combinations 300/12.5 mg & 300/25 mg….
Teva UK Limited is recalling the batch 12J30KC because there have been a small number of reports of damaged vials and there are concerns, therefore, that there is potential for…
Full details of the 2014 Pharmaceutical Price Regulation Scheme PPRS can be found here
CAELYX® (pegylated liposomal doxorubicin) supply shortages reported in Canada please click here for further information This supply shortage does not reflect a safety or quality issue with the product in…